NYSE:ABBV
ABBVIE INC.
- Stock
locale
United States
market
STOCKSindustry
Drug Manufacturers - Generalwebsite
www.abbvieinvestor.comipo date
Jan 02, 2013
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus